All lobbying filings
FORBES-TATE
Lobbying for HALOZYME THERAPEUTICS, INC. · U.S. Biotechnology Company
Filing
1st Quarter - Report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 15, 2025
Income
$60,000.00
What the client paid this registrant for the period.
Client based in
California
Government bodies contacted
4
Lobbying activity
1
Issues related to biopharmaceutical research, development, and manufacturing.